Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, October 25 2016 2:28pm ET - U.S. Markets close in 1 hour and 32 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Monday, Oct 24, 2016
·Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice
at - Mon 3:22 pm ET
·Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results
at - Mon 2:16 pm ET
·Valeant Pharmaceuticals (VRX) Stock Could Double in Three Years, LMM CIO Bill Miller Says
at - Mon 1:52 pm ET
·Alkermes Depression Drug Shows Good Results (ALKS)
at Investopedia - Mon 9:30 am ET
·PetMed Express D/B/A 1-800-PetMeds Announces Its Second Quarter Financial Results and Its $0.19 Per Share Quarterly Dividend
GlobeNewswire - Mon 8:00 am ET
·Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?
- Mon 7:55 am ET
Friday, Oct 21, 2016
·Alkermes, Inc. -- Moody's Alkermes' FORWARD-5 trial is credit positive
- Fri Oct 21
·Alkermes (ALKS) Stock Soars on Trial Results, Upgrades
at - Fri Oct 21
·Alkermes' depression drug trial win could be a test case for the FDA
at - Fri Oct 21
·[$$] Alkermes Shares Surge
at The Wall Street Journal Online - Thu Oct 20
Thursday, Oct 20, 2016
·Headline Risk Is Still Poison for These Stocks
- Thu Oct 20
·Alkermes shares soar more than 40% after depression drug results
at MarketWatch - Thu Oct 20
·​Depression drug by Waltham’s Alkermes aces late-stage trial
at - Thu Oct 20
·Alkermes Surge by a Record 47% on Depression Pill Trial Success
at Bloomberg - Thu Oct 20
·Alkermes Surges as Depression Drug Hits Goal in Late-Stage Trial
Bloomberg - Thu Oct 20
·Alkermes Depression Drug Finds Success on Third Study Attempt
at - Thu Oct 20
·Alkermes Announces Positive Topline Results From FORWARD-5 Pivotal Phase 3 Study of ALKS 5461 for Major Depressive Disorder
Business Wire - Thu Oct 20
·BMRA: Base Business Bounces Back, InFoods Continues To Attract Who’s-Who of IBS
- Thu Oct 20
Tuesday, Oct 18, 2016
·Delcath Issues Letter to Stockholders
PR Newswire - Tue Oct 18
·Multi-million Dollar DTRA Funding for Biodefense Research with Aradigm’s Inhaled Ciprofloxacin
Business Wire - Tue Oct 18
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?